(Q40412257)

English

Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions

scientific article published on June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

ovarian carcinoma

1 reference

based on heuristic

inferred from title

author name string

Sylvia Stadlmann

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Albert Amberger

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Juergen Pollheimer

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Guenther Gastl

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Felix Albert Offner

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Raimund Margreiter

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Alain Gustave Zeimet

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

784-789

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: identification of transforming growth factor-beta as a suppressive factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Activated human neutrophils express vascular endothelial growth factor (VEGF).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.017

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.02.017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40412257&oldid=1897128613"